216 related articles for article (PubMed ID: 6176924)
1. Chemotherapy with the modified Bagshawe protocol for poor prognosis metastatic trophoblastic disease.
Weed JC; Barnard DE; Currie JL; Clayton LA; Hammond CB
Obstet Gynecol; 1982 Mar; 59(3):377-80. PubMed ID: 6176924
[TBL] [Abstract][Full Text] [Related]
2. A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in "poor prognosis" metastatic gestational trophoblastic disease: a Gynecologic Oncology Group study.
Curry SL; Blessing JA; DiSaia PJ; Soper JT; Twiggs LB
Obstet Gynecol; 1989 Mar; 73(3 Pt 1):357-62. PubMed ID: 2536911
[TBL] [Abstract][Full Text] [Related]
3. Modified Bagshawe's regimen in high-risk gestational trophoblastic disease.
Wong LC; Choo YC; Ma HK
Gynecol Oncol; 1986 Jan; 23(1):87-93. PubMed ID: 3002917
[TBL] [Abstract][Full Text] [Related]
4. Gestational trophoblastic disease.
Hammond CB; Olt GJ
Curr Ther Endocrinol Metab; 1994; 5():567-70. PubMed ID: 7704794
[No Abstract] [Full Text] [Related]
5. Poor-prognosis gestational trophoblastic disease: an update.
Surwit EA; Alberts DS; Christian CD; Graham VE
Obstet Gynecol; 1984 Jul; 64(1):21-6. PubMed ID: 6204257
[TBL] [Abstract][Full Text] [Related]
6. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
Soper JT; Evans AC; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
[TBL] [Abstract][Full Text] [Related]
7. High-risk metastatic gestational trophoblastic disease. A new dose-intensive, multiagent chemotherapeutic regimen.
Surwit EA; Childers JM
J Reprod Med; 1991 Jan; 36(1):45-8. PubMed ID: 1848900
[TBL] [Abstract][Full Text] [Related]
8. Metastatic gestational trophoblastic disease: secondary chemotherapy.
Lurain JR; Piver MS
N Y State J Med; 1980 Feb; 80(2):234-7. PubMed ID: 6246471
[No Abstract] [Full Text] [Related]
9. A new combination chemotherapy for resistant trophoblastic disease.
Surwit EA; Suciu TN; Schmidt HJ; Hammond CB
Gynecol Oncol; 1979 Aug; 8(1):110-8. PubMed ID: 222651
[No Abstract] [Full Text] [Related]
10. Methotrexate monotherapy for high-risk gestational trophoblastic neoplasia after therapy with etoposide, methotrexate, and dactinomycin: a case report.
Taran A; Ignatov A; Smith B; Bischoff J; Costa SD
Am J Obstet Gynecol; 2008 Nov; 199(5):e6-8. PubMed ID: 18984073
[TBL] [Abstract][Full Text] [Related]
11. Management of low-risk metastatic gestational trophoblastic tumors.
DuBeshter B; Berkowitz RS; Goldstein DP; Bernstein MR
J Reprod Med; 1991 Jan; 36(1):36-9. PubMed ID: 1848898
[TBL] [Abstract][Full Text] [Related]
12. Vinblastine, cisplatin and bleomycin as salvage therapy for refractory high-risk metastatic gestational trophoblastic disease.
DuBeshter B; Berkowitz RS; Goldstein DP; Bernstein M
J Reprod Med; 1989 Mar; 34(3):189-92. PubMed ID: 2470902
[TBL] [Abstract][Full Text] [Related]
13. Plasma methotrexate levels in patients receiving etoposide, methotrexate, actinomycin, cyclophosphamide, and vincristine (EMA-CO) chemotherapy for trophoblastic neoplasia.
Kohorn EI
Gynecol Oncol; 1993 Sep; 50(3):300-4. PubMed ID: 8406191
[TBL] [Abstract][Full Text] [Related]
14. [Methotrexate in gynecologic oncology].
Isonishi S; Terashima Y
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1896-900. PubMed ID: 8978793
[TBL] [Abstract][Full Text] [Related]
15. Treatment of metastatic trophoblastic disease with poor prognosis.
Surwit EA; Hammond CB
Obstet Gynecol; 1980 May; 55(5):565-70. PubMed ID: 6245395
[TBL] [Abstract][Full Text] [Related]
16. Placental site trophoblastic tumor: an overview.
Bonazzi C; Urso M; Dell'Anna T; Sacco S; Buda A; Cantú MG
J Reprod Med; 2004 Aug; 49(8):585-8. PubMed ID: 15457847
[TBL] [Abstract][Full Text] [Related]
17. Management of high-risk gestational trophoblastic disease.
Surwit EA
J Reprod Med; 1987 Sep; 32(9):657-62. PubMed ID: 2822919
[TBL] [Abstract][Full Text] [Related]
18. "Poor prognosis" metastatic gestational trophoblastic disease: the prognostic significance of the scoring system in predicting chemotherapy failures.
Mortakis AE; Braga CA
Obstet Gynecol; 1990 Aug; 76(2):272-7. PubMed ID: 2164651
[TBL] [Abstract][Full Text] [Related]
19. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
Homesley HD
J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
[TBL] [Abstract][Full Text] [Related]
20. 5-day methotrexate for women with metastatic gestational trophoblastic disease.
Soper JT; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
Gynecol Oncol; 1994 Jul; 54(1):76-9. PubMed ID: 8020843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
